Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Available × mifamurtide × 1 year × Clear all

Status

Available 1 Active not recruiting 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Interventions

3-Iodobenzylguanidine 2 zolbetuximab 1 venetoclax 1 ulixertinib 1 tisagenlecleucel 1 tipifarnib 1 telisotuzumab vedotin 1 talazoparib 1 selinexor 1 ruxolitinib 1 ribociclib 1 mifamurtide 1 idecabtagene vicleucel 1 gedatolisib 1 fluorodopa F 18 1 fluorocholine 1 dodecyl maltoside 1 ceritinib 1 carbon-11 methionine 1 balstilimab 1 axicabtagene ciloleucel 1 asciminib 1 Sunitinib 1 Proton Pump Inhibitors 1 Peripheral Blood Stem Cell Transplantation 1 Methionine 1 Magnetic Resonance Spectroscopy 1 LY3023414 1 Immunotherapy, Adoptive 1 Hydrocortisone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04571229 2026-03-18

Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma

Memorial Sloan Kettering Cancer Center

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡